Lexaria Bioscience Corp (LEXX)

[Shawking]

Remdesivir dreams again tonight. In this version an announcement is made:
'Lexaria and the National Research Council of Canada advise that in-vitro testing of an oral formulation of Remdisivir with DehydraTECH, in animal models (mice), has shown that the oral DehydraTECH formulation was as effective entering the bloodstream as the IV administered drug. Further tests revealed that the DehydraTECH formulation was even more effective at crossing the Blood/Brain Barrier than the IV administered drug.
Lexaria has applied to Health Canada and the FDA for an emergency use application and is immediately proceeding to a Phase 1 clinical trial.'
Hope Springs Eternal!
Sweet Dreams!